
PureTech Health plc — Investor Relations & Filings
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-06-04 | English | |
| Holding(s) in Company | 2026-05-29 | English | |
| Holding(s) in Company | 2026-05-27 | English | |
| Holding(s) in Company | 2026-05-22 | English | |
| Correction - Holding(s) in Company | 2026-05-15 | English | |
| PRTC To Showcase Deupirfenidone at ATS Conference | 2026-05-13 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47969531 | Holding(s) in Company | 2026-06-04 | English | ||
| 47891182 | Holding(s) in Company | 2026-05-29 | English | ||
| 47777829 | Holding(s) in Company | 2026-05-27 | English | ||
| 46846084 | Holding(s) in Company | 2026-05-22 | English | ||
| 46349644 | Correction - Holding(s) in Company | 2026-05-15 | English | ||
| 45566389 | PRTC To Showcase Deupirfenidone at ATS Conference | 2026-05-13 | English | ||
| 44107110 | Holding(s) in Company | 2026-05-08 | English | ||
| 43307615 | Holding(s) in Company | 2026-05-07 | English | ||
| 39399460 | PureTech's Seaport Prices Upsized IPO Nasdaq: SPTX | 2026-05-01 | English | ||
| 38655488 | Notice of Meeting for 2026 AGM | 2026-04-29 | English | ||
| 38642553 | Proxy Form for 2026 AGM | 2026-04-29 | English | ||
| 38637441 | 20-F - PureTech Health plc (0001782999) (Filer) | 2026-04-29 | English | ||
| 38625474 | Annual Report and Accounts 2025 | 2026-04-29 | English | ||
| 38625445 | Annual Report and Accounts 2025 | 2026-04-29 | English | ||
| 38495071 | 6-K - PureTech Health plc (0001782999) (Filer) | 2026-04-29 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for PureTech Health plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BY-HEALTH CO.,LTD
Researches, develops, and distributes dietary supplements, …
|
300146 | CN | Manufacturing |
|
C4 Therapeutics, Inc.
Clinical-stage biopharma developing targeted protein degrad…
|
CCCC | US | Manufacturing |
|
Cadrenal Therapeutics, Inc.
A late-stage biopharmaceutical company developing novel ant…
|
CVKD | US | Manufacturing |
|
CalciMedica, Inc.
Develops CRAC channel inhibitors for acute inflammatory and…
|
CALC | US | Manufacturing |
|
Calidi Biotherapeutics, Inc.
Develops stem cell platforms to deliver oncolytic viruses f…
|
CLDI | US | Manufacturing |
|
Calliditas Therapeutics
Biopharma company developing and commercializing treatments…
|
CALTX | SE | Manufacturing |
|
Callitas Health Inc.
Clinical-stage biomedical company developing pharma and OTC…
|
MPHMF | CA | Manufacturing |
|
CALTH. Inc
Develops in vitro diagnostic tools for point-of-care and se…
|
402420 | KR | Manufacturing |
|
Cambrex
A CDMO providing drug substance, drug product, and analytic…
|
CBM | US | Manufacturing |
|
CAMBRIDGE NUTRITIONAL SCIENCES PLC
Develops and manufactures diagnostic tests for food sensiti…
|
CNSL | GB | Manufacturing |
PureTech Health plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4932/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4932 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4932 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4932 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4932}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PureTech Health plc (id: 4932)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.